1. Home /
  2. Pharmaceuticals


Drug Stocks Often Trade in a Pack, but Not Now. Here Are Leaders and Laggards

Although pharmaceutical companies as a group are keeping pace with the broader market, there is considerable divergence in individual names.

This Pharma Is Starting to Recover Nicely

Here's a trade idea for Aurinia Pharmaceuticals.

It's Time to Reevaluate Moderna's Charts

Here's what I think we'll see up ahead.

Bearish Bets: 3 Downgraded Stocks You Should Consider Shorting This Week

These names are displaying both quantitative and technical deterioration.

CVS Health's Charts Are Pretty Sickly

The stock has been in a weak trend for more than a year.

Can Pfizer's Charts and Fundamentals Get on the Same Page?

The pharmaceutical giant gained an analyst's buy recommendation but its technical signals are lackluster at best.

Vertex Appears a Bit Under the Weather Ahead of Earnings

The charts give a reading of weakness ahead for this pharma name.

Here's How to Trade Bristol-Myers Squibb After Earnings

If you're a long-term BMY bull, here's what the charts suggest.

Amgen Is Casting a Bearish Technical Hue in Advance of Earnings

The biotech giant's charts have displayed weakness of late as it prepares to report fourth-quarter results.

With Pfizer Firmly in Value Territory, Here's What Investors Are Missing

The stock is already down about 15% in 2023 as the pharmaceutical giant gets set to report earnings.